Abstract
OBJECTIVE: This study aimed to evaluate the clinical effect of transcutaneous pelvic floor magnetic stimulation combined with urination training in the treatment of overactive bladder (OAB) in children. METHODS: In this study, the clinical data of 42 children with OAB who were treated with transcutaneous pelvic floor magnetic stimulation combined with the urination training method at our hospital from March 2022 to December 2022 (Group B) were collected. The clinical data of 50 children with OAB who were treated with the urination training method at our hospital from December 2021 to February 2022 (Group A) were used as controls. The clinical efficacy of treatment was compared between the two groups. RESULTS: After 2 weeks of treatment, the Akbal scale scores of the two groups were significantly lower than those before treatment (P < 0.05). After two weeks of treatment, the Akbal score of Group B was significantly lower than that of Group A (P < 0.05). The maximum voiding volume (MVV), average voiding volume (AVV), maximum urinary flow rate, average urinary flow rate and voiding frequency significantly differed between the two groups as well as before and after treatment (P < 0.05). Specifically, the MVV, AVV and maximum urinary flow rate, average urinary flow rate and voiding frequency significantly differed between the two groups after treatment, and the improvement value of Group B was greater than that of Group A (P < 0.05). After 2 weeks of treatment, the Akbal score revealed that the degree of improvement in frequent urination throughout the day, the degree of urgency and quality of life of patients in Group B were significantly greater than those in Group A (P < 0.05). CONCLUSION: Transcutaneous pelvic floor magnetic stimulation combined with urination training was effective in the treatment of children with OAB. Compared with urination training alone, this method can achieve better therapeutic effects and can more effectively improve the symptoms, bladder capacity and urination function of children after 2 weeks of treatment.